Receptos Inc., of San Diego, said that Ono Pharmaceuticals Co. Ltd., of Osaka, Japan. has elected to amend and expand their existing collaboration agreement to include transfer to Ono of the Receptos G-protein-coupled receptor (GPCR) technology platform, a high resolution protein crystal structure determination technology, which enables rational drug design for the GPCR therapeutic target class.